Showing results (31-40 of 106) with videos related to
Sort By:
Pageof 11
Biofabrication|January 16, 2023
Additive manufacturing and performance of bioceramic scaffolds with different hollow strut geometriesShumin Pang, Dongwei Wu, Aleksander Gurlo, et al.International Journal of Molecular Sciences|October 26, 2024
Oncolytic Coxsackievirus B3 Strain PD-H Is Effective Against a Broad Spectrum of Pancreatic Cancer Cell Lines and Induces a Growth Delay in Pancreatic KPC Cell Tumors In VivoAnja Geisler, Babette Dieringer, Leslie Elsner, et al.Antiviral Therapy|April 2, 2016
Biological antivirals for treatment of adenovirus infectionsKatrin Schaar, Carsten Röger, Tanja Pozzuto, et al.Antiviral Research|November 7, 2016
Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virusSandra Pinkert, Babette Dieringer, Sabine Diedrich, et al.Biochimie|November 14, 2017
Comprehensive identification of proteins binding to RNA G-quadruplex motifs in the 5' UTR of tumor-associated mRNAsTatsuo Serikawa, Christos Spanos, Annekathrin von Hacht, et al.Nucleic Acids Research|June 12, 2003
Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNAArnold Grünweller, Eliza Wyszko, Birgit Bieber, et al.Oligonucleotides|July 24, 2010
Rapid construction of adeno-associated virus vectors expressing multiple short hairpin RNAs with high antiviral activity against echovirus 30Diana Rothe, Gisela Wajant, Hans-Peter Grunert, et al.Plos One|August 27, 2015
Targeting Highly Structured RNA by Cooperative Action of siRNAs and Helper Antisense Oligomers in Living CellsMariola Dutkiewicz, Agata Ojdowska, Jakub Kuczynski, et al.Antiviral Research|April 10, 2024
Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV virusesBeatrice Tolksdorf, Julian Heinze, Daniela Niemeyer, et al.FEBS Letters|December 17, 2009
Application of small interfering RNAs modified by unlocked nucleic acid (UNA) to inhibit the heart-pathogenic coxsackievirus B3Denise Werk, Jesper Wengel, Suzy L Wengel, et al.Pageof 11